← Alle mensen

CL

Chunling Liu

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicen...
The Lancet. Oncology · 2026-02
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as eerstelijns treatment of metastatic n...
The Lancet. Oncology · 2025-07
Ivonescimab plus chemotherapie bij EGFR-variant NSCLC: fase II
JAMA · 20 augustus 2024
Iruplinalkib versus crizotinib bij ALK-positief NSCLC: fase III
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024-06
CZS-werkzaamheid van furmonertinib versus gefitinib bij EGFR-gemuteerd NSCLC
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022-11
Aumolertinib versus gefitinib als eerstelijns bij EGFR-gemuteerd NSCLC: AENEAS fase III
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 september 2022
Niraparib als onderhoud bij uitgebreid SCLC na chemotherapie: fase II
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-08